An AMCP Webinar

Whether you're a student pharmacist exploring career possibilities, a resident or fellow planning your next step, a pharmacist considering a career transition, or a managed care pharmacy professional looking to deepen your perspective and share the value of our profession with others, this webinar is for you.

Join AMCP and the Membership Committee for an engaging overview of managed care pharmacy and the vital role it plays in improving patient access to medications, supporting evidence-based care, and helping navigate today's complex healthcare landscape.

A Science & Innovation Webinar, presented by AbbVie Medical Affairs.

The objective of this Pharmacokinetic/Pharmacokinetic (PK/PD) analysis is to evaluate Bruton's Tyrosine Kinase (BTK) occupancy at doses included in the US Prescribing Information (USPI) dose modifications for adverse reactions recommendations.

• Review the dose modification guidance for adverse reactions included in the US Prescribing Information.
• Explain the PK/PD findings showing BTK occupancy at doses included in the USPI dose modifications for adverse reactions.

An AMCP CPE Webinar.

Federal drug pricing policy is moving rapidly from the Medicare Drug Price Negotiation Program (MFP) toward renewed interest in most-favored-nation (MFN)–style approaches, with ripple effects far beyond their stated intent. As price controls intersect with rebates, Medicaid best price, 340B, and growing price transparency, traditional pricing and formulary strategies are being tested in real time. Drawing on perspectives from policy, economics, Medicaid, employers, and formulary leaders, this session unpacks how these policies transmit through markets—and where theory breaks down in practice. Attendees will explore unintended consequences, including launch delays, benefit disruptions, rebate erosion, and shifting stakeholder trust. The discussion emphasizes practical implications for payers navigating affordability pressures, political uncertainty, and evolving pricing architectures. 

An AMCP Precision Medicine LINK Group Webinar.

Biomarker testing is central to delivering precision oncology, but adoption still varies by tumor type and care setting. Drawing on IQVIA's new Advancing Precision Oncology report, we will walk through current testing trends and the levers — clinical evidence, guideline inclusion, and institutional champions — that move biomarkers from evidence into everyday practice, along with the barriers still holding adoption back. We'll close with a quick pipeline update on what's next in oncology therapeutics.

Join us as AMCP Market Insights shares exclusive findings from our recent multi-stakeholder expert roundtable on treatment-resistant depression. This webinar will break down payer perspectives on clinical data, address the looming provider network shortage, and outline actionable strategies to prepare your behavioral health network for these emerging interventional treatments. Attendees will walk away with concrete recommendations on removing care barriers, updating coverage frameworks, and driving cross-industry collaboration to evaluate, cover, and operationalize these therapies safely and effectively.